Form 8-K - Current report:
SEC Accession No. 0000927066-21-000164
Filing Date
2021-10-28
Accepted
2021-10-28 16:09:43
Documents
14
Period of Report
2021-10-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dva-20211028.htm   iXBRL 8-K 36564
2 EX-99.1 dva-93021ex991.htm EX-99.1 761273
6 davitalogorgbfa75a.jpg GRAPHIC 32400
  Complete submission text file 0000927066-21-000164.txt   1028568

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dva-20211028.xsd EX-101.SCH 2053
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dva-20211028_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dva-20211028_pre.xml EX-101.PRE 12656
7 EXTRACTED XBRL INSTANCE DOCUMENT dva-20211028_htm.xml XML 10731
Mailing Address 2000 16TH STREET DENVER CO 80202
Business Address 2000 16TH STREET DENVER CO 80202 310-536-2668
DAVITA INC. (Filer) CIK: 0000927066 (see all company filings)

EIN.: 510354549 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14106 | Film No.: 211358315
SIC: 8090 Services-Misc Health & Allied Services, NEC